![Warren Lammert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Warren Lammert
Amministratore Delegato presso
Granite Point Capital Management LP
Profilo
Warren Burnet Lammert is the founder of Granite Point Capital Management LP, serving as Chief Investment Officer since 2004, and Tevard Biosciences, Inc., serving as Chairman since 2017.
Current jobs include Director at Receptor Life Sciences, Inc. and Director at Engage Therapeutics, Inc. Former jobs include Chairman at Cerebral Therapeutics, Inc., Director at Biscayne Pharmaceuticals, Inc., Director at Epilepsy Foundation, Director at Biscayne Neurotherapeutics, Inc., Research Associate at Fred Alger Management LLC, and Portfolio Manager at Janus Henderson Investors US LLC from 1987 to 2003.
Education includes an undergraduate degree from Yale University, conferred in 1984, and a graduate degree from London School of Economics & Political Science, conferred in 1989.
Posizioni attive di Warren Lammert
| Società | Posizione | Inizio |
|---|---|---|
Granite Point Capital Management LP
 Granite Point Capital Management LP Investment ManagersFinance Great Point Capital invests globally and focuses on small- to mid-cap US equities. | Amministratore Delegato | 13/01/2004 |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Develops rescue therapy for uncontrolled epileptic seizures | Direttore/Membro del Consiglio | - |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases | Fondatore | 31/08/2017 |
Receptor Life Sciences, Inc.
 Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutic products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Warren Lammert
| Società | Posizione | Fine |
|---|---|---|
Janus Henderson Investors US LLC
 Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Gestore di Portafoglio-Azioni | 31/12/2003 |
Fred Alger Management LLC
 Fred Alger Management LLC Investment ManagersFinance FAM is a growth manager that uses proprietary, bottom-up, fundamental research to identify companies that are undergoing positive dynamic change. The firm invests in companies experiencing high unit volume growth and/or companies undergoing a positive life cycle change. | Analyst-Equity | 31/12/1986 |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases | Presidente | - |
Biscayne Pharmaceuticals, Inc.
 Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Direttore/Membro del Consiglio | - |
Biscayne Neurotherapeutics, Inc.
 Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Direttore/Membro del Consiglio | - |
Formazione di Warren Lammert
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
93
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Fred Alger Management LLC
Fred Alger Management LLC Investment ManagersFinance FAM is a growth manager that uses proprietary, bottom-up, fundamental research to identify companies that are undergoing positive dynamic change. The firm invests in companies experiencing high unit volume growth and/or companies undergoing a positive life cycle change. | Finance |
Janus Henderson Investors US LLC
Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Finance |
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Provides welfare services to people with epilepsy | Commercial Services |
Granite Point Capital Management LP
Granite Point Capital Management LP Investment ManagersFinance Great Point Capital invests globally and focuses on small- to mid-cap US equities. | Finance |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Health Technology |
Receptor Life Sciences, Inc.
Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutic products | Health Technology |
Engage Therapeutics, Inc.
Engage Therapeutics, Inc. BiotechnologyHealth Technology Develops rescue therapy for uncontrolled epileptic seizures | Health Technology |
Cerebral Therapeutics, Inc.
Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases | Commercial Services |
Tevard Biosciences, Inc.
Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapies for the treatment of genetic diseases | Commercial Services |
